Category: Workers Comp

599 posts found

image of cream someone rubs on their skin for pain

WCRI Publishes Report on Drug Payment Trends

Dermatological agents remained a significant cost driver, in part due to physician dispensing and delivery pharmacies, which accounted for a significant number of high-cost transactions.

Psychedelic Updates

States Continue to Push for Psychedelic-Assisted Therapy Programs

Connecticut, Georgia, and Oklahoma enacted laws to enable certain programs, while a Louisiana bill awaits gubernatorial decisions.

This Month's Must Read

Rescheduling Questions: How the Marijuana Landscape Could Soon Change

The rescheduling of marijuana may introduce significant implications for clinical research, drug development, and downstream utilization.

Industry Insights

WCRI Publishes 2026 CompScope Benchmarks

Claim costs increased 6% per year from 2022-2025 in the median study state, with state-level variations.

Psychedelic Developments

White House Issues Executive Order on Psychedelics

The order seeks to accelerate clinical trials, data sharing, drug approvals, and possibly rescheduling.

Legislation & Policy

Texas Approves Audit of Topical Analgesics

After soliciting stakeholder feedback on possible audit topics, the DWC prioritized a study of topical analgesics by the Medical Quality Review Panel.

Industry Insights

NCCI Reports on Workplace Violence

Workplace assaults have increased at a rate of 5.3% per year from 2011-2022, primarily impacting health care and social assistance workers.

Medmonitor

FDA Approves New Oral GLP-1 Tablets, Foundayo, for Treatment of Obesity

The once-daily tablet starts at an 0.8 mg dosage, which is then steadily increased at 30-day intervals, based on treatment response and tolerability.

This Month's Must Read

In the Long Run: How Long COVID Impacts Workers’ Comp

While severe cases are less common, they greatly impact costs, recovery, and return to work.

Legislation & Policy

Pennsylvania Proposes Reimbursement Caps for Compounds and Topicals

The bill would create a $400, 30-day supply cap for compound drugs.

Marijuana Developments

New Jersey Proposes Marijuana Reimbursement in Workers’ Comp and Group Health

Companion bills S3984 and A1023 would require health insurance coverage for the medical use of cannabis under certain circumstances.

Image of a doctor and patient, with a laptop sitting around recording notes

Innovation

American Medical Association Reports on Increased Physician Use of AI

From a poll of 1,692 physicians, over 80% used AI in some context – twice the percent noted in 2023.

Healthe Developments

AI and the Adjuster: Driving Efficiency Without Losing the Human Touch

Mike Theis, AVP of Product and Analytics, joins other industry experts featured in Risk and Insurance’s latest article on how AI can reduce clutter to allow for a more human touch.

This Month's Must Read

Wear and Tear: A Breakdown of Degenerative Comorbid Conditions

With the workforce growing older, degenerative conditions may have a growing impact on claims.

Legislation & Policy

Florida Appeals Court Rules in Favor of Carriers and Employers on Physician-Dispensed Drugs

While injured workers have an absolute choice over their pharmacist, physicians are not considered pharmacists and therefore not entitled to reimbursement.

Prev 1 2 3 4 5 … 36 37 38 39 40 Next